FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to dimephosphone nicotinoylhydrazone of formula (I) which may be used in medicine and veterinary science: I.
EFFECT: what is presented is a new compound showing high anti-tuberculosis activity and low toxicity.
2 cl, 1 ex, 3 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
DIMEPHOSPHONE ISONICOTINOYLHYDRAZONE WITH ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2457212C1 |
DIALKYL(2-METHYL-4-OXOPENT-2-YL)PHOSPHINE OXIDE PYRIDINOYL HYDRAZONES, HAVING ANTITUBERCULOUS ACTIVITY | 2012 |
|
RU2498990C1 |
TRAIZINES HAVING ANTI-TUBERCULOSIS ACTIVITY | 2010 |
|
RU2431633C1 |
ANTITUBERCULOUS COMPOSITE MEDICATION | 2009 |
|
RU2406518C1 |
SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
ANTI-TUBERCULOSIS DRUG BASED ON (Z)-3-(3,3-DIMETHYL-2-OXOBUTYLIDENE) -3,4-DIHYDRO-2H-1,4-BENZOXAZIN-2-ONE AND A METHOD FOR ITS SYNTHESIS | 2020 |
|
RU2748748C1 |
METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
CULTURE MEDIUM FOR DETERMINING DRUG SUSCEPTIBILITY OF M tuberculosis TO MAIN ANTI-TUBERCULOSIS DRUGS | 2010 |
|
RU2470071C2 |
METHOD OF DETERMINING DRUG SUSCEPTIBILITY OF TUBERCULOSIS MYCOBACTERIA | 2003 |
|
RU2255977C1 |
METHOD FOR DETERMINING THE SENSITIVITY OF MYCOBACTERIUM TUBERCULOSIS CULTURES TO PYRAZINAMIDE | 2022 |
|
RU2792782C1 |
Authors
Dates
2013-01-10—Published
2011-07-20—Filed